Skip to Content
Søg Menu
Hæmatologi
Velkommen til Hæmatologi

Få seneste nyt inden for Hæmatologi

Overlevelsesgevinst for skrøbelige CLL-patienter i behandling med Imbruvica og Venclyxto

  • / Carsten Utoft Niemann

EHA | Kongresside

Her finder du abstracts, online artikler, MEDtalks med internationale og nationale key opinion leaders fra EHA.

Se mere

Seneste magasin fra hæmatologi

Onkologi/Hæmatologi • Nr. 10 • 2023

  • LAG3-hæmmere ændrer immunterapiens behandlingslandskab
  • Highlights fra ASCO GI & GU
  • Highlights fra ASH 2022
  • Myelomatose: Geografisk betinget? 
Get access

Clinical Editorial Board

Agoston Gyula Szabo

Afdelingslæge. Afd. for Blodsygdomme, Rigshospitalet
Caspar da Cunha-Bang

Afdelingslæge, PhD Klinik for blodsygdomme Rigshospitalet

Seneste nyt fra hæmatologi

Artikler

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Hæmatologi / Evangelos Terpos / Jan Andreasen

Belamaf shows deeper, longer-lasting myeloma response

/ Hæmatologi / Jan Andreasen

EHA 2023: Professor Pieter Van Vlierberghe Posthumously Decorated with David Grimwade Award

/ Hæmatologi / BestPractice Nordic

Promising Results from EHA23: Gilteritinib as Posttransplant Maintenance Therapy for FLT3-ITD AML Patients

/ Hæmatologi / BestPractice Nordic
Se oversigt

MEDtalks

Epcoritamab with rituximab and lenalidomide (R2) for patients with high-risk follicular lymphoma

/ Hæmatologi / Anna Sureda Balari

Gilteritinib for patients with newly diagnosed AML

/ Hæmatologi / Mark Levis

MURANO study supports the use of fixed-duration VenR in R/R CLL

/ Hæmatologi / Arnon Kater

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Hæmatologi / Evangelos Terpos

Meet the experts • Akut myeloid leukæmi • Nr. 1

Get access

Nyt fra Medicinrådet

Lyt og læs om seneste anbefalinger fra Medicinrådet

Se mere

Seneste nyt inden for

AML

FLT3 Inhibitor Gilteritinib Shows Potential in Post-Transplant Maintenance for AML

/ Hæmatologi / Mark J. Levis

EHA23 – Novel CAR Therapy for AML Shows Favorable Pre-Clinical Outcomes

/ Hæmatologi / BestPractice Nordic

The Link Between Breast Cancer and Hematologic Cancers

/ Hæmatologi / Cathrine Fonnesbech Hjorth

An update on new treatments for acute myeloid leukemia

/ Hæmatologi / Hans Beier Ommen

Treatment Options for FLT3 mutant acute myeloid leukemia

/ Hæmatologi / Eunice Wang
Se oversigt

CLL

What is new from EHA23 regarding treatment Strategies in First-Line CLL?

/ Hæmatologi / Barbara Eichhorst

New Research from EHA23 Points to Similar Effectiveness of Acalabrutinib and Zanubrutinib in R/R CLL Treatment

/ Hæmatologi / Alan Z. Skarbnik

UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies

/ Hæmatologi / Dima El-Sharkawi

MURANO 7-års data viser fortsat effekt ved R/R CLL – men giver ikke svar på alle spørgsmål

/ Hæmatologi / Carsten Utoft Niemann

New CLL Study Supports Inclusion of Venetoclax Plus Obinutuzumab in Treatment Guidelines

/ Hæmatologi / Othman Al-sawaf
Se oversigt

Lymfomer

News from EHA23 – A promising treatment option for follicular lymphoma

/ Hæmatologi / Ryan Jacobs

Risk of dementia in older patients treated with chemotherapy for lymphoma

/ Neurologi / Eva Futtrup Maksten

Therapeutic options for patients with primary refractory or early relapsed DLBCL

/ Hæmatologi / Manali Kamdar

Promising Findings for R/R Large B-cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Hæmatologi / Martin Hutchings

Dansk/amerikansk studie viser øget dødelighed for patienter med CLL og type 2-diabetes

/ Hæmatologi / Emelie Hamotal Curovic Rotbain
Se oversigt

Myelomatose

Fredrik Schjesvold

EHA23 Insights into the Changing Landscape of Myeloma Treatments

/ Fredrik Schjesvold
EHA23Myelomatose Play the Video
Sagar Lonial

Exciting News for CAR T Cell Therapy to Heavily Treated Patients with Multiple Myeloma

/ Sagar Lonial
ASCO23EHA23CAR-TMyelomatose Play the Video
Rakesh Popat

Integrating BCMA-Based Combination Regimens in Early R/R Multiple Myeloma

/ Rakesh Popat
EHA23Myelomatose Play the Video
Hent flere

ASH | Kongresside

Vi publicerer de vigtigste highlights fra ASH i form af abstracts, online artikler, MEDtalks med internationale og nationale key opinion leaders.

Se mere

Artikler fra Hæmatologi

Late-breaking from ASH22 – Let’s keep the standard consolidation therapy with HDC-ASCT for PCNSL patients

/ BestPractice Nordic
ASH22Lymfom

Diffust Storcellet B-Celle-Lymfom (DLBCL) – Plasma-albumin som prognostisk markør

/ Kim Oren Gradel / Jelena Jelicic
Lymfom

Ibrutinib keeps on delivering now as first-line treatment for older patients with mantle cell lymphoma

/ BestPractice Nordic
EHA22Lymfom
Hent flere

EHA | Kongresside

Her finder du abstracts, online artikler, MEDtalks med internationale og nationale key opinion leaders fra EHA.

Se mere

COVID-19 Perspektiver

Vi udgiver løbende artikler og MEDtalks med forskellige sundhedsperspektiver og kommentarer om COVID-19.

Find alle COVID-19 perspektiverne her

Mere fra hæmatologi

Navigating CLL Treatment: Decoding Small-Molecule Inhibitor Sequencing and Combination Therapies

/ Clement Chung
CLL

Evolving Concepts in Chronic Lymphocytic Leukemia (CLL) – Optimizing Treatment Strategies and Patient Experience

/ BestPractice Nordic
EHA23CLL

High Expression of the Inhibitory Checkpoint Receptor TIGIT by CD8+ T-cells in Multiple Myeloma

/ Katrine Fladeland Iversen
MyelomatoseT-celler

God praksis for udvikling af machine learning-modeller

/ Simon Lebech Cichosz / Thomas Kronborg / Morten H. Jensen
Teknologi

Er risikoen for myelomatose geografisk betinget?

/ Lise Dueholm Bertelsen
Myelomatose

Psoriasis artrit-patienter, TNF-hæmmere og hæmatologiske cancere

/ René Lindholm Cordtz / Lene Dreyer
Reumatoid artritisCancer
Indlæs mere

Back to top